These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24894408)

  • 1. The unmet needs of all adults with ADHD are not the same: a focus on Europe.
    Ginsberg Y; Beusterien KM; Amos K; Jousselin C; Asherson P
    Expert Rev Neurother; 2014 Jul; 14(7):799-812. PubMed ID: 24894408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADHD and transitions to adult mental health services: a scoping review.
    Swift KD; Sayal K; Hollis C
    Child Care Health Dev; 2014 Nov; 40(6):775-86. PubMed ID: 24164052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthood.
    Treuer T; Chan KLP; Kim BN; Kunjithapatham G; Wynchank D; Semerci B; Montgomery W; Novick D; Dueñas H
    Asia Pac Psychiatry; 2017 Jun; 9(2):. PubMed ID: 27552649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.
    Ramos-Quiroga JA; Montoya A; Kutzelnigg A; Deberdt W; Sobanski E
    Curr Med Res Opin; 2013 Sep; 29(9):1093-104. PubMed ID: 23742051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young adults with ADHD: an analysis of their service needs on transfer to adult services.
    Taylor N; Fauset A; Harpin V
    Arch Dis Child; 2010 Jul; 95(7):513-7. PubMed ID: 20530525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADHD and offenders.
    Young S; Thome J
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():124-8. PubMed ID: 21906010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Services for young people with attention deficit/hyperactivity disorder transitioning from child to adult mental health services: a national survey of mental health trusts in England.
    Hall CL; Newell K; Taylor J; Sayal K; Hollis C
    J Psychopharmacol; 2015 Jan; 29(1):39-42. PubMed ID: 25237121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorder.
    Montano CB; Young J
    Postgrad Med; 2012 Sep; 124(5):23-32. PubMed ID: 23095423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults.
    Asherson P
    Expert Rev Neurother; 2005 Jul; 5(4):525-39. PubMed ID: 16026236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
    Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
    Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the transition of care for adolescents with attention-deficit/hyperactivity disorder.
    Robb A; Findling RL
    Postgrad Med; 2013 Jul; 125(4):131-40. PubMed ID: 23933901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The course of attention deficit hyperactivity disorder (ADHD) over the life span].
    Koumoula A
    Psychiatriki; 2012 Jun; 23 Suppl 1():49-59. PubMed ID: 22796973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of adult ADHD in Europe.
    Retz W; Retz-Junginger P; Thome J; Rösler M
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():89-94. PubMed ID: 21906003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adult Attention Deficit/Hyperactivity Disorder (ADHD): current issues].
    Bader M; Perroud N
    Rev Med Suisse; 2012 Sep; 8(354):1761-2, 1764-5. PubMed ID: 23097912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Awareness of adult attention-deficit/hyperactivity disorder (ADHD) in Greece].
    Pehlivanidis A
    Psychiatriki; 2012 Jun; 23 Suppl 1():60-5. PubMed ID: 22796974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis.
    Adler LA; Wilens T; Zhang S; Dittmann RW; D'Souza DN; Schuh L; Durell TM
    Clin Ther; 2012 Feb; 34(2):363-73. PubMed ID: 22285724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.